European Celecoxib Trial in Primary Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Celecoxib|OTHER: Placebo
Sponsor: Imperial College London
Collaborators: Institute of Cancer Research, United Kingdom